Atara Biotherapeutics Inc... (ATRA)
8.49
1.12 (15.20%)
At close: Jan 28, 2025, 3:59 PM
8.38
-1.30%
After-hours Jan 28, 2025, 04:59 PM EST
Cashflow (Annual)
Get detailed ratio statement breakdowns, uncovering price to free cash flow ratio, price per earnings, and much more.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 |
| Net Income | -276.13M | -228.30M | -340.14M | -306.62M | -290.98M | -230.70M | -119.49M | -79.05M | -57.22M | -28.01M | -8.77M | -12.33M |
| Depreciation & Amortization | 4.83M | 5.65M | 9.35M | 8.33M | 7.07M | 3.73M | 956.00K | 383.00K | 48.00K | 6.00K | 4.00K | n/a |
| Stock-Based Compensation | 45.39M | 53.84M | 53.87M | 51.35M | 51.70M | 33.82M | 23.10M | 16.78M | 10.25M | 10.10M | 1.71M | 876.00K |
| Other Working Capital | 20.48M | -11.44M | 39.91M | 67.00M | -8.36M | 16.96M | 5.04M | -1.71M | 5.18M | 161.00K | 609.00K | n/a |
| Other Non-Cash Items | 17.59M | -40.15M | 2.04M | 1.53M | 1.03M | 260.00K | 732.00K | 2.58M | 3.58M | 748.00K | -4.00K | 9.86M |
| Deferred Income Tax | n/a | n/a | 1.79M | 958.00K | -303.00K | -1.89M | n/a | n/a | n/a | 526.00K | n/a | n/a |
| Change in Working Capital | 15.34M | -61.47M | 52.58M | 63.69M | -4.15M | 15.00M | 7.20M | -725.00K | 6.19M | -3.00K | 1.09M | n/a |
| Operating Cash Flow | -192.98M | -270.43M | -220.52M | -180.76M | -235.63M | -179.77M | -87.50M | -60.02M | -37.16M | -16.63M | -5.97M | -2.48M |
| Capital Expenditures | -1.22M | -4.19M | -10.58M | -4.51M | -5.73M | -35.92M | -20.23M | -3.02M | -290.00K | -46.00K | -3.00K | -27.00K |
| Acquisitions | n/a | 94.77M | -32.84M | 116.22M | 161.00K | n/a | n/a | -83.74M | n/a | n/a | n/a | n/a |
| Purchase of Investments | -83.65M | -180.59M | -301.13M | -425.87M | -270.23M | -466.49M | -176.46M | -304.93M | -379.78M | -95.53M | n/a | n/a |
| Sales Maturities Of Investments | 208.71M | 292.97M | 333.97M | 309.65M | 336.26M | 306.13M | 296.60M | 391.69M | 160.13M | 12.21M | n/a | n/a |
| Other Investing Acitivies | 25.00K | 207.15M | 32.84M | -116.22M | 66.19M | -160.36M | -1.20M | 83.74M | -194.00K | -83.32M | n/a | n/a |
| Investing Cash Flow | 123.87M | 202.96M | 22.26M | -120.73M | 60.46M | -196.29M | 98.71M | 83.74M | -220.13M | -83.36M | -3.00K | -27.00K |
| Debt Repayment | -947.00K | -518.00K | -254.00K | -389.00K | -486.00K | -528.00K | n/a | n/a | n/a | n/a | n/a | n/a |
| Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -94.00K | n/a | n/a | n/a | n/a |
| Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Other Financial Acitivies | 821.00K | 31.71M | 5.50M | 4.99M | 655.00K | 17.19M | 892.00K | 506.00K | -4.21M | 13.82M | 53.38M | 10.09M |
| Financial Cash Flow | 2.01M | 53.08M | 103.94M | 427.57M | 188.79M | 357.54M | 20.05M | 506.00K | 259.23M | 70.27M | 53.38M | 15.12M |
| Net Cash Flow | -67.10M | -14.39M | -94.32M | 126.09M | 13.62M | -18.52M | 31.25M | 24.22M | 1.85M | -29.72M | 47.41M | 12.62M |
| Free Cash Flow | -194.20M | -274.62M | -231.10M | -185.27M | -241.36M | -215.70M | -107.73M | -63.05M | -37.45M | -16.67M | -5.97M | -2.50M |